坎地沙坦酯对高血压谷峰比值、平滑指数的影响  被引量:2

Study of T/P rate and smoothness index of candesartan cliexetil on essential hypertension

在线阅读下载全文

作  者:石世强[1] 何强先[1] 桑更生[1] 陈以强[1] 张隽[1] 

机构地区:[1]蚌埠市第三人民医院心内科,安徽省蚌埠233000

出  处:《中国基层医药》2009年第7期1239-1240,共2页Chinese Journal of Primary Medicine and Pharmacy

摘  要:目的探讨坎地沙坦酯治疗轻中度原发性高血压的疗效及对患者血压谷峰比值和平滑指数的影响。方法50例轻中度原发性高血压患者,口服坎地沙坦酯8mg,每天1次,疗程4周,于治疗前后进行24h动态血压监测并计算其谷峰比值(T/P)和平滑指数。结果治疗4周后,24h平均收缩压(148.2±10.7)mmHg和24h平均舒张压(97.6±6.5)mm Hg、白昼平均收缩压(152.5±9.8)mm Hg和平均舒张压(96.0±5.3)mmHg、夜间平均收缩压(138.3±7.6)mmHg和平均舒张压(89.2±8.3)mmHg、收缩压负荷值(87.5±12.2)%和舒张压负荷值(36.48±26.4)%与治疗前的(130.2±7.2)mmHg、(79.5±7.8)mm Hg、(133.4±7.2)mmHg、(81.8±6.6)mmHg、(121.9±7.3)mmHg、(72.1±7.4)mmHg、(84.7±9.9)%、(26.7±8.3)%比较差异均有统计学意义(均P〈0.01);治疗后收缩压和舒张压T/P分别为70%和63%、平滑指数分别为(1.21±0.82)和(1.13±0.51),均符合要求。结论坎地沙坦酯治疗原发性高血压安全有效,均能获得良好的T/P比值及平滑指数。Objective To study the T/P rate and smoothness index of Candesartan Cliexetil on slight and middle essential hypertension. Methods 50 patients with slight and middle essential hypertension were treated by Candesartan Cliexetil 8mg taken orally everyday,the course of treatment was 4 weeks. 24h ambulatory blood pressure monitoring(ABPM) was given before and after treatment ,the T/P rate and smoothness index were calculated. Results Four weeks after treatment, 24h SBP( 148.2 ± 10. 7)mm Hg and 24 h DBP(97. 6 ±6.5) mm Hg,dSBP( 152. 5 ± 9. 8)mm Hg and dDBP(96. 0 ±5.3)mm Hg,nSBP(138.3 ±7. 6)mm Hg and nDBP(89.2 ±8. 3)mm Hg,SBP load ( 87. 5 ± 12. 2) % and DBP load ( 36.48 ± 26.4) % with prereatment ( 130. 2 ± 7. 2) mm Hg, ( 79. 5 ± 7. 8 ) mm Hg, (133.4 ±7.2)mm Hg,(81.8 ±6. 6)mm Hg,(121.9 ±7. 3)mm Hg, (72. 1 ±7.4)mm Hg,(84. 7 ±9.9)% ,(26. 7 ± 8. 3) % have significant difference (P 〈 0. 01 ). T/P rates were SBP 70% and DBP 63 %. Smoothness indexes were SBP( 1.21 ± 0. 82) and DBP( 1.13 ±0. 51 ). Conclusion Candesartan cilexetil in the treatment of essential hypertension is safe and effective,can get a good T/P ratio and smoothness index.

关 键 词:血压 谷峰比值 平滑指数 坎地沙坦酯 

分 类 号:R544[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象